Key facts
- This page summarizes Sandeep Laumas's Form 3 filing for Hillstream BioPharma Inc. (THAR).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2022, 20:50.
Sandeep Laumas - 11 Jan 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (THAR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- THAR
- Reported as of
- 11 Jan 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 11 Jan 2022, 20:50:54 UTC
- Prior SEC filing
- 12 Jul 2021
- Next SEC filing
- 20 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandeep Laumas
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandeep Laumas filed Form 3 for Hillstream BioPharma Inc. (THAR) on 11 Jan 2022.
Change
- Previous filing in this sequence was filed on 12 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HILS
holding
Common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 636,008
- Date
- 11 Jan 2022
- Ownership
- See Footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HILS
holding
Derivative
Convertible Note
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 11 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- Exercise price
- Footnotes
- F2
HILS
holding
Derivative
Convertible Note
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 11 Jan 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Sandeep Laumas is the Managing Member of Bearing Circle Capital LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
Footnote F2
On May 10, 2021, the Registrant issued the Reporting Person a $60,000 note which matures on the earlier of (i) May 10, 2024 and (ii) the closing of the Next Equity Financing. The note shall automatically convert into the type of Equity Securities issued in the Next Equity Financing and shall be equal to the quotient obtained by dividing the outstanding amount of the note by the lesser of (i) 80% of the price paid per Equity Security in the Next Equity Financing and (ii) an equity valuation of the Registrant of $50 million. "Next Equity Financing" means the next sale (or series of related sales) by the Registrant of its Equity Securities pursuant to which the Registrant receives gross proceeds of not less than $7.5 million (inclusive of the aggregate amount of debt securities converted into Equity Securities upon conversion or cancellation of notes). "Equity Securities" means, subject to certain exceptions, the Registrant's common stock and common stock equivalents.
Footnote F3
On August 4, 2021, the Registrant issued the Reporting Person a Subordinated Convertible Promissory Note (the "August Note") in the principal amount of $40,000. The August Note matures upon the earlier of (i) August 4, 2024 and (ii) the closing of the Next Equity Financing. The principal amount of the August Note together with accrued interest thereon shall automatically convert into the type of Equity Securities issued in the Next Equity Financing. The number of Equity Securities to be issued upon conversion of the August Note shall be equal to the quotient obtained by dividing the outstanding principal amount of the August Note together with interest accrued thereon by the lesser of (i) 80% of the price paid per Equity Security in the Next Equity Financing and (ii) an equity valuation of the Registrant of $50 million.